Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Find a Suitable Dose of Exl-111 for Further Researchallergic diseaseRecruitingPhase 12026-09-22NCT07356713

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Excellergy Inc.1

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
CMAXAdelaideAustralia4
New Zealand Clinical Research OPCO LtdAucklandNew Zealand1